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NeurotransmissionCyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase predominantly active in the
nervous system where it regulates several processes such as neuronal migration, cytoskeletal dynamics,
axonal guidance, and neurotransmission.
We constructed a position speciﬁc scoring matrix (PSSM) based on a dataset of sites shown to be phosphor-
ylated both in vivo and in vitro by Cdk5. This dataset was curated manually through an exhaustive search of
published experimental data. We then used this PSSM to perform a search in the mouse proteome through
Scansite, a web-based tool for matching sequence patterns in large databases. Considering a stringent
cut-off score of 0.5, we identiﬁed 354 new putative sites present in 291 proteins. In order to assess the robust-
ness of our results, ten random subsets (of 80 sites each) of the original dataset were used to construct new
PSSMs, which were then used as input for a new Scansite search, leading to the recovery of 81% of the 354
sites by at least 5 PSSMs.
In order to reduce the number of false positives in our sequence-based approach, we evaluated which of
these predicted sites were phosphorylated in vivo as determined by multiple phosphoproteomics studies
carried out through mass spectrometry and available in the PhosphoSitePlus database. This step resulted in
a very promising list of 132 putative phosphorylation sites for Cdk5, of which, 51 are speciﬁcally phosphor-
ylated in brain tissue, and some are involved in functions regulated by Cdk5 such as axonal growth, synaptic
plasticity and neurotransmission. Other phosphorylation sites in our list suggest that Cdk5 might regulate
processes through mechanisms not previously recognized such as the control of mRNA splicing.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Cdk5 is an atypical member of the Cdk family, as its activity is
regulated through the binding of two non-cyclin activators which are
present in postmitotic neurons, namely p35 (Cdk5Rr1) and p39
(Cdk5r2). Additionally, Cdk5 is not directly involved in cell cycle regula-
tion, but controls multiple aspects of neuronal function such as axonal
elongation, neuronal migration and synaptic transmission [1]. Recently
it has been shown that Cdk5 participates in other physiological func-
tions that occur outside of the nervous system (reviewed in [2,3]).
Cdks are among the most promiscuous kinases, being able to
phosphorylate hundreds of substrate proteins [4]. In fact, a global
analysis of yeast has found that Cdk1 can phosphorylate between 181
and 308 target proteins [5,6]. Kinase diversity and pathway overlap
precludes the conduction of global studies in the higher eukarya
proteomes, where the search for new kinase-speciﬁc substrates has
been mainly performed through computational methods. Such strate-
gies present many disadvantages, mainly the large proportion of falselault).
rights reserved.positives in the results obtained. Until now, only one bioinformatic
study has been reported to predict phosphorylation sites for a Cdk in
the yeast proteome [7]. Moreover and to our knowledge few studies
have succeeded in experimentally verifying computationally predicted
sites [8–10].
In this work, we performed the ﬁrst systematic computational
search for putative phosphorylation sites for a Cdk family member
(Cdk5) in a mammalian proteome (Mus musculus). One of the main
pitfalls for the bioinformatic determination of novel kinase-speciﬁc
phosphorylation sites at a proteome-wide scale is the selection of
an appropriate classiﬁcation method to distinguish between true
and false substrates. Currently the most widely accepted methods to
achieve this task are position-speciﬁc scoring matrices (PSSMs) [11],
hidden markov models (HMMs) [12], artiﬁcial neural networks
(ANNs) [13] and support vector machines (SVMs) [14].
PSSMs are a relatively simplemethod, which have been successfully
used for the prediction of novel phosphorylation sites in proteome-
wide studies [11,15]. PSSMs adequately consider the modular nature
of the kinase-substrate interactions, where the catalytic domain of the
kinase establishes direct contact with a linear motif of the substrate.
Such a modular characteristic explains the tendency of kinases to
phosphorylate a particular sequence motif, which in the case of Cdk5
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As bona ﬁde phosphorylation sites in a proteome are estimated to be
less than 10% of all potentially phosphorylated residues, even at a low
false positive rate, the expected number of false positive candidates
precludes experimental validation [16].
Considering these limitations, we developed a strategy that
considers a protein as a good candidate to be phosphorylated by Cdk5
if the predicted site derived from our bioinformatic analyses has been
actually identiﬁed as phosphorylated in vivo in studies usingmass spec-
trometry. Phosphoproteomic studies describe tens of thousands of in
vivo phosphorylated sites; however, most of those sites are still orphan
for the kinase responsible for this modiﬁcation. As phosphoproteomics
studies increase in number, size and depth, we approach a point at
which all the phosphorylated sites in a proteome will be known [17],
allowing a signiﬁcant increase in the reliability of database-wide stud-
ies. In this paper we used the sequences known to be phosphorylated
by Cdk5 to predict new sites modiﬁed by this kinase. These putative
sites were then evaluated for their in vivo phosphorylation status, in
order to improve the reliability of the prediction of new substrates for
Cdk5 phosphorylation in the mouse proteome.2. Results and discussion
2.1. Characterization of known substrates of Cdk5
Table S1 lists the known substrates for Cdk5 and their respective
phosphorylation sites as derived frompublished records (seeMethods).
Sequence analysis reveals that only 49% of the substrates contain the
canonical consensus motif, (Ser/Thr)-Pro-X-(Arg/Lys/His). There is
high prevalence of suboptimal motifs containing only the minimal
(Ser/Thr)-Pro dipeptidemotif which is not exclusive for Cdk5 substrates
since previous studies have shown a similar behavior for Cdk1 and Cdk2
substrates,where 39–67% of thephosphorylation sitesmatch only to the
minimal proline-directed consensus motif [18,19]. Therefore, large
representation of non-consensus motifs makes it especially difﬁcult to
predict phosphorylation sites for these kinases. To overcome this, we
focused our effort on developing a PSSM (Table 1), which provides a
better description of the phosphorylation sites, including sequences
distant from the consensus motif. PSSMs have been previously
implemented for the search of novel substrates for Cdc28 (Cdk1) in
yeast [7], where the construction of the PSSM was based on kinetic
data from in vitro phosphorylation of a peptide library. Unlike thisTable 1
Amino acid preferences of Cdk5 around the phosphorylation site. In green are highlighted s
pletion (log (score)≥–2).
A
Ala Cys Asp Glu Phe Gly His Iso Lys Le
-6 1.06 0.47 0.44 0.90 0.00 1.77 0.41 0.97 1.30 0.4
-5 1.20 0.92 1.09 0.89 0.29 0.80 0.80 0.48 1.47 0.6
-4 0.60 0.46 1.74 1.19 0.57 0.64 0.00 0.24 0.37 1.0
-3 1.35 0.92 1.09 0.89 1.14 0.64 1.21 0.00 0.37 0.9
-2 0.90 0.46 0.87 0.59 0.86 0.16 0.00 0.48 1.29 0.5
-1 0.75 0.46 0.44 0.44 0.57 0.96 0.80 0.72 1.29 1.4
0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
2 1.05 0.46 0.22 0.74 1.14 1.75 0.40 0.72 1.47 0.7
3 0.90 0.46 0.22 0.30 0.29 0.48 2.01 0.72 3.86 0.4
4 1.05 0.46 1.09 0.89 0.29 1.11 2.41 1.43 0.55 0.5
5 1.51 0.46 1.09 0.30 0.57 1.75 1.21 1.48 1.47 0.6
6 2.41 0.00 1.31 0.74 0.29 0.64 0.00 0.24 0.73 0.6
7 1.20 0.46 1.09 1.19 0.57 0.32 0.40 0.24 0.73 1.1
Po
si
ti
on
s
8 2.11 0.46 0.22 0.44 1.14 0.96 0.40 0.48 0.92 0.9reported approach, our PSSM was based only on sites shown to be
directly and physiologically phosphorylated by Cdk5, which may
increase the accuracy of prediction, since the selectivity of protein
kinases in vivo is higher than in vitro [20].
In addition to the sequence motifs found in substrates, other
features have been implemented to improve the reliability of the phos-
phorylation site descriptor. Most commonly used are the structural
disorder degree [21] and the clustering of phosphorylation sites in
protein sequences [22]. We evaluated the collected dataset of known
Cdk5 phosphorylation sites with a disorder prediction tool, showing
that the majority of the sites (76%) were located in areas of structural
disorder (PrDOS score>0.5, Fig. 1). However, the analysis of the
unphosphorylated (Ser/Thr)-Pro motifs showed the same distribution,
indicating a general preference for enrichment of the (Ser/Thr)-Pro
dipeptide in areas of intrinsic structural disorder (Fig. 1, red curve).
Therefore, in the analyses of Cdk5 phosphorylated sites, structural
disorder lacks a predictive value.2.2. PSSM performance
In order to test the Cdk5 phosphorylation site prediction capacity
of our PSSM, we used Scansite to evaluate all Ser and Thr residues in
the proteins derived from our bibliographic search (Table S1). Based
on our PSSM, Scansite calculated a single numerical value for each
15-residue long sequence centered on a proline preceded by a Ser
or Thr. Lower values reﬂect a better match to the Cdk5 PSSM. Within
the Cdk5-phosphorylated proteins, we considered as false positives,
all those predicted sites which had not been experimentally shown
to be phosphorylated by this kinase, with the exception of those
located in transmembrane or extracellular segments of membrane
proteins (according to the Swiss-Prot topological annotations as
“Extracellular” or “Transmembrane”), which were discarded. This is
exempliﬁed by the data collected for the amyloid precursor protein
(APP), where Cdk5-dependent phosphorylation has been shown to
occur at Thr668 [23]. In addition to the correct identiﬁcation of
this site, our PSSM-mediated analysis predicted one additional site
(Thr306) positioned at the extracellular domain, which therefore was
not considered as a false positive. Fig. 2A shows the distribution of
true positives, true negatives, false positives and false negatives as a
function of the Scansite score. The PSSM identiﬁed 92.7% of the sites
as true positives, but was unable to discriminate properly between
these sites and the false positives, especially at higher score values.cores that show signiﬁcant enrichment (log (score)≥2) and in red those exhibiting de-
mino acids
u Met Asn Pro Gln Arg Ser Thr Val Trp Tyr
2 0.97 0.88 1.34 1.10 1.11 1.50 0.97 1.91 0.00 0.00
3 0.96 1.17 1.49 1.31 1.29 1.36 0.58 0.69 0.00 1.96
5 0.00 2.04 1.32 0.87 0.55 2.85 1.34 0.34 0.00 0.78
5 0.00 1.17 1.49 0.66 2.02 1.11 1.34 0.86 1.68 0.78
3 2.39 0.88 2.65 1.09 1.10 1.61 1.15 1.37 0.00 0.39
7 0.96 0.58 1.16 1.31 1.10 1.86 1.34 0.69 0.00 0.78
0 0.00 0.00 0.00 0.00 0.00 8.78 4.80 0.00 0.00 0.00
0 0.00 0.00 15.9 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4 0.00 0.88 1.16 1.75 2.02 0.99 1.15 0.51 0.84 0.39
2 0.00 0.29 1.16 0.44 4.59 0.62 0.77 0.51 0.00 0.78
3 0.96 1.46 1.16 1.09 1.84 1.24 1.34 0.86 0.84 0.39
3 0.48 0.29 0.50 1.53 2.20 1.36 1.34 0.34 0.00 0.78
3 1.91 1.17 1.82 1.31 0.92 1.36 0.58 1.20 0.00 0.78
6 1.43 0.29 1.99 1.09 1.65 0.87 1.73 0.86 1.68 0.00
5 0.96 1.17 1.66 1.97 0.55 1.61 0.77 0.51 0.00 0.78
Fig. 3. Comparative performance of different methods for ﬁnding Cdk5-
phosphorylated sites in the mouse proteome. The performance of a search in the
mouse proteome using our custom Cdk5 PSSM in retrieving known Cdk5-dependent
phosphorylation sites (Table S1)was comparedwith the performance of three previously
implementedmethods for searching kinase-speciﬁc phosphorylation sites: Scansite (with
the default Cdk5 PSSM), NetPhosK (with a cut-off score of 0.5) and GPS. Our strategy
identiﬁed a greater percentage of known phosphorylation sites (90%) and assigned to
them a comparatively better ranking in the overall results than previously implemented
methods.
Fig. 1. Structural disorder around Cdk5 phosphorylation sites. Box plots of the PrDOS
score around the phosphorylation site (in red). The bottom and the top of the box
are the 25th and 75th percentiles respectively; the central band is the median; the
whiskers extend to the most extreme data points. The red line represents the median
of the S/T[P] sites not phosphorylated by Cdk5. The gray horizontal line represents
the limit score between order/disorder (PrDOS score=0.5) and the dashed orange
line represents the average score of all amino acids in the Cdk5 substrates.
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false positives. Therefore we set up 0.5 as the threshold value, with a
false positive percentage of 1%, which is the point where the number
of false positives starts to increase exponentially. The compromise be-
tween sensitivity and speciﬁcity of a classiﬁer is commonly represented
by a receiver operating characteristic (ROC) curve (Fig. 2B). The area
under our ROC curve (AUC) is a measure of the probability of correctly
classifying a Cdk5-phosphorylated residue. In our case, the estimated
AUC is 0.7545, indicating a good performance of our predictions.
2.3. Database search
We then used our Cdk5 PSSM to perform a search of the mouse
proteome at the Scansite website, producing 400 sites with a lower
score than 0.5 (Table S2). These 400 sites were present in 332 proteins,
representing 2% of the total proteins in the database. Twenty of these
sites had been previously described as Cdk5 substrates. Although this
represents a low retrieving rate, our strategy clearly outperforms several
previously published methods including NetPhosK [24], GPS [25] and
Scansite in a search for Cdk5-dependent phosphorylation sites in the
whole mouse proteome (Fig. 3). This is surprising, because NetPhosK
and GPS are signiﬁcantly more sophisticated methods for kinase-
speciﬁc phosphorylated site prediction. The main pitfall of PSSMs is
that they are unable to detect patterns in which combinations of
amino acids are relevant. In this line, it was recently found that
interpositional dependence on substrate sequence was minimal forFig. 2. The Cdk5 PSSM identiﬁes bona ﬁde phosphorylation sites in known Cdk5 substrates.
line), true negatives (brown line) and false negatives (blue line) for a given PSSM score t
value was set to 0.5. B. ROC curve plotting including AUC value. The diagonal (AUC=0.5) rvarious kinases, including one member of the Cdk family (Cdk1) [26],
indicating that PSSMs can provide good representations of the phos-
phorylation sites. Four of the predicted sites are present in Cdk5 sub-
strates but have yet to be reported as phosphorylated by this kinase;
therefore, we considered them as false positives. Additionally, 22 of
the predicted sites were topologically inaccessible to Cdk5, because
they are located in transmembrane or extracellular segments of mem-
brane proteins. Therefore, our search identiﬁed 354 sites present in 291
proteins, as new putative phosphorylation sites for Cdk5. To examine
the robustness of the new predicted sites, ten different PSSMs were cre-
ated out of 80 random sites from the in vivo and in vitro positive dataset
to scrutinize the samemouse database using Scansite. This search recov-
ered 286 of the original 354 new putative sites (81%), with each predict-
ed site being present in at least 5 of these shufﬂed PSSMs (Table S4).
Additionally, 60 of these sites were found between the 400 best results
for Cdk5 in a search of the mouse proteome by NetPhosK (Table S4), a
kinase-speciﬁc predictor based onANNs,which is trainedwith adifferent
dataset and uses a nine-residuewindowaround the phosphorylation site
(unlike the 15 employed in the construction of our PSSM).
Using the PhosphoSitePlus database, we checked whether the 354
new putative sites were actually phosphorylated in vivo. Of these,
only 130 sites (in 108 proteins) have been reported to be phosphory-
lated in vivo in high-throughput studies (Table S3). These sites repre-
sent the most likely candidates to be phosphorylated by Cdk5 in the
mouse proteome. Considering that brain tissue displays high Cdk5
activity, we summarized our results on the putative novel Cdk5-A. Plot of the calculated distribution of true positives (green line), false positives (red
hreshold. Note that the false positives were reduced to less than 1% when the cut-off
epresents the performance of a random classiﬁer.
Table 2
Putative sites phosphorylated by CDK-5 detected in vivo in brain samples.
Protein Gene
name
Site(s) Commentaries
mRNA processing and splicing
Protein SON Son S1937(a,b) Acts as a mRNA splicing co-factor. Essential for nuclear speckle organization.
RNA-binding protein with serine-rich domain 1 Rnps1 S27(d) Component of the active spliceosome. Associated with CDK-11.
Phosphorylation by CK-2 in the N-terminal represses its activity.
Serine/arginine repetitive matrix protein 1 Srrm1 S308(b) Component of the active spliceosome. Involved in numerous
pre-mRNA processing events.
Serine/arginine repetitive matrix protein 2 Srrm2 S882(a,b),
S1998(a,b,c)
Component of the active spliceosome. Knockdown causes defects
in cell migration.
Serine/arginine-rich splicing factor 1 Srsf1 S227(b), S238(b) Phosphorylation in S227 and S238 by Dyrk1A represses the splicing
of tau exon 10.
Thyroid hormone receptor-associated protein 3 Thrap3 S55(b,d) Component of the spliceosome. Mediates mRNA splicing and degradation.
Zinc phosphodiesterase ELAC protein 2 Elac2 S195(a) Uncharacterized protein. Associated with γ-tubulin complex.
Synaptic transmission
Activated CDC42 kinase 1 Tnk2 S622(b) Non-receptor tyrosine and serine/threonine kinase activated downstream
of Cdc42. Localizated in presynaptic axons terminals and dendritic spines.
Caskin-1 Caskin1 S1304(f,g) Scaffold protein that interacts with CASK and cytoplasmic tail of neurexin-1.
Dapper homolog 3 Dact3 S374(a) Scaffold protein that interacts with Wnt/β-catenin signaling components.
Highly expressed in adult cerebral cortex.
Metabotropic glutamate receptor 1 Grm1 S1154(a,b) G-protein coupled receptor for glutamate.
Microtubule-associated serine/threonine-protein kinase 1 Mast1 S163(a,b) Postsynaptic protein that interacts with β2-syntrophin.
Nitric oxide synthase, brain Nos1 S287(a) Produces nitric oxide dependent on calcium/calmodulin activation.
Paralemmin-1 Palm S116(a,b) Essential for dendritic spine maturation.
Phosphatidylinositol 4-kinase type 2-alpha Pi4k2a S51(a,b) Concentrated in Golgi complex and synapses, accounts for most
of the phosphotidylinositol-4 kinase activity in the brain.
Protein bassoon Bsn S1497(a,c) Involved in the organization of axonal active zone and neurotransmitter release.
Protein piccolo Pclo S4562(a,b,f) Scaffold protein involved in organization of axonal active zone and synaptic
vesicle trafﬁcking.
Protein TANC1 Tanc1 S445(a,b,e) Postsynaptic scaffold protein required for spine maturation and spatial memory.
Protein TANC2 Tanc2 S1480 (f) Postsynaptic scaffold protein required for spine maturation. KO is embryonic lethal.
Transcriptional regulation
AF4/FMR2 family member 4 Aff4 S175(d) Associated with Cyclin T1/CDK-9. May be have a role in transcriptional regulation
and RNA splicing.
B-cell CLL/lymphoma 9-like protein Bcl9l S988(a) Enhanced β-catenin/TCF-mediated transcription.
B-cell lymphoma/leukemia 11A Bcl11a S332(a) Zinc ﬁnger transcription factor that regulates DCC and map1b gene expression.
Cyclin-K Ccnk S329(a,b,d) Regulatory subunit of CDK9, that phosphorylates carboxy-terminal domain
of RNA polymerase II to promotes transcriptional elongation.
E1A-binding protein p400 Ep400 S321(a) Helicase component of Tip60 acetyltransferase multiprotein complex.
Forkhead box protein K1 Foxk1 S406(a,b) Transcription factor that acts as co-repressor with Sin3.
PC4 and SFRS1-interacting protein Psip1 S176(a,d,e,f) A transcriptional activator that binds to promoter elements of heat shock
and stress-related genes.
Transcription initiation factor TFIID subunit 9 Taf9 T159(a) TATA-binding protein (TBP)-associated factor essential for the regulation
of RNA polimerase II-mediated transcription.
Zinc ﬁnger protein AEBP2 Aebp2 S21(a) Gli-type zinc ﬁnger transcription factor mainly expressed in cells
of neural crest origin.
Cytoskeleton dynamics, cell adhesion and vesicular trafﬁc
Cingulin-like protein 1 Cgnl1 S252(b) Regulates RhoA and Rac1 activity in tight junctions through interaction
with Tiam1 and GEF-H1.
Hepatocyte cell adhesion molecule Hepacam S386(f) Immunoglobulin-like cell adhesion molecule.
Plakophilin-4 Pkp4 S336(b,d,f,g) Member of a family of armadillo proteins, localizated in desmosomes
and adherens junctions. Regulate RhoA activity during cytokinesis.
Pleckstrin homology domain-containing family A member 7 Plekha7 S904(a,b) Associate microtubules with E-cadherin. Recruiting cingulin-like
protein 1 to adherens and tight junctions.
Protein transport protein Sec24A Sec24a T227(a) Regulates ER export by binding to LL signals.
Rootletin Crocc S1483(a) Major component of ciliary rootlet. Contributes to centrosome cohesion.
Scavenger receptor class F member 2 Scarf2 S640(b) Probable adhesion protein.
VPS10 domain-containing receptor SorCS1 Sorcs1 S1155(b) Type I transmembrane receptor that mediates intracellular trafﬁcking.
Associates with the amyloid precursor protein and regulates Aβ secretion.
Others functions
Choline-phosphate cytidylyltransferase A Pcyt1a S323(a) Catalyzes the rate-limiting step of phosphatidylcholine synthesis.
Ubiquitously expressed.
Choline-phosphate cytidylyltransferase B Pcyt1b S323(a) Catalyzes the rate-limiting step of phosphatidylcholine synthesis.
Mainly expressed in the brain. Phosphorylated in vivo and in vitro by Cdk5.
DNA replication licensing factor MCM2 Mcm2 S27(b,h) Component of the putative DNA helicase essential for “once for cell cycle”
DNA replication initiation.
F-box/WD repeat-containing protein 10 Fbxw10 S942(d) Substrate-speciﬁc adapter for RING uniquitin ligases.
Promotes heterochromatin protein (HP)-1α y-1β degradation.
Insulin receptor substrate 2 Irs2 S388(a,b) Intracellular adapter of insulin and insulin-like growth factor I receptors.
Kelch-like protein 9 Klhl9 S603(b) Substrate-speciﬁc adapter for Cul3 ubiquitin ligase.
Promotes Aurora B remotion from chromosomes by ubiquitination
and degradation.
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Table 2 (continued)
Protein Gene
name
Site(s) Commentaries
Others functions
Nuclear-interacting partner of ALK Zc3hc1 S394(d) Substrate-speciﬁc adapter for SCF ubiquitin ligase.
Controllers’ mitotic entry through Cyclin B1 degradation.
Protein FAM63A Fam63a S440(b) Unknown function.
Protein shisa-6 homolog Shisa6 S398(a,f) Unknown function.
Serine/threonine-protein kinase 32C Stk32c S18(b,d) Unknown function.
Sister chromatid cohesion protein PDS5 homolog B Pds5b S1166(a,b,d),
S1368(a)
Regulatory factor of cohesion complex that maintains sister chromatid
linkage until anaphase. Highly expressing in postmitotic neurons.
TBC1 domain family member 13 Tbc1d13 S184(a) May act as a GAP for Rab GTPases.
(a) Huttlin et al., 2010; (b) Wisniewski et al., 2010; (c) Collins et al., 2005; (d) Tweedie-Cullen et al., 2009; (e) Trinidad et al. 2008; (f) Trinidad et al., 2006; (g) Munton et al., 2007;
(h) Ballif et al., 2004.
225D.A. Bórquez et al. / Genomics 101 (2013) 221–228dependent phosphorylated sites detected by publishedmass spectrom-
etry studies carried out using brain tissue (Table 2).
2.4. Proteins involved in mRNA processing and splicing
Amongst the putative substrates of Cdk5 identiﬁed here, we found
proteins that participate in the processing and splicing of mRNA.
Although there is no substantial evidence for a role of Cdk5 in these
processes, an inhibitory role for Cdk5 in the incorporation of exon
10 in the microtubule associated protein tau has been described
[27]. Tau exon 10 splicing is controlled by several proteins, including
the serine/arginine-rich splicing factor 1 (Srsf1) (also called ASF/SF2)
whose activity is repressed by a Dyrk1a-mediated phosphorylation of
three residues (Ser227, Ser234 and Ser238) [28]. Interestingly, two of
these sites in ASF/SF2 are identiﬁed by our PSSM as candidates for
Cdk5 phosphorylation (see Table 2), thus presenting a likely explana-
tion of the role of Cdk5 in the splicing of tau exon 10.
2.5. Proteins involved in neurotransmission
The presynaptic nerve terminal, the main site for neurotransmitter
release, is a complex cytomatrix where synaptic vesicle trafﬁc occurs in
a continuous cycle of exocytosis, endocytosis and recycling, along with
continuous mobilization between various internal vesicles pools [29].
Cdk5 is known to be an active player at presynaptic terminals, as reﬂected
by themultiple targets that localize to this compartment (Fig. 4, red stars).
We predict that two of the major scaffold proteins present at the presyn-
aptic cytomatrix, Piccolo (Pclo) and Bassoon (Bsn) could be novel targets
for Cdk5 (Fig. 4, orange stars). Additionally, our data suggests that
phosphatidylinositol (PI)-4 kinase type IIα (PI4KIIα) (Pi4k2a) could also
be a likely substrate. Interestingly, PI4KIIα in conjunction with other
known Cdk5 targets such as synaptojanin 1 (Synj1) (Fig. 4, red stars)
and PI(4) phosphate 5 kinase type I (PIPKI)-γ (Pip5k1c) (Fig. 4, red
stars), regulates PI metabolism at presynaptic terminals (Fig. 4).
Cdk5 acts as a potent suppressor of neurotransmitter release, as its
inhibition unlocks the reserve synaptic vesicle pool and accelerates exo-
cytosis kinetics, although themechanisms involved in this phenomenon
remain unknown [30]. Interestingly Piccolo, like Cdk5, is a negative reg-
ulator of synaptic vesicle exocytosis, and acts by reducing vesicle trans-
location from the resting pool to the active zone [31]. Our predicted
phosphorylation site on Piccolo (Ser4562) is located between the PDZ
domain (residues 4391–4506) and an atypical Ca2+-binding domain
(C2A, residues 4588–4730). The PDZ domain acts as a docking site for
Epac2 (Rapgef4), which mediates cAMP-induced exocytosis [32],
whereas the low calcium-afﬁnity C2A domain could act as a presynaptic
calcium sensor that mediates the response to repetitive stimulation
[33]. Potentially, Cdk5-mediated phosphorylation of Piccolo could regu-
late the exocytosis events controlled by these two second messengers.
On the other hand, the putative phosphorylation site identiﬁed in
Bassoon (Ser1497) is located between three adjacent binding sites for
the dynein light chains 1 and 2 (DLC1 and DLC2, encoded by Dynll1
and Dynll2) found at residues 1433–1437, 1509–1513 and 1535–1539,respectively. The binding of DLCs to Bassoon is involved in retrograde
transport of synaptic components in the axons [34], and could be depen-
dent on Cdk5 dependent modulation. Interestingly, the C. elegans Cdk5
homolog inhibits dynein-dependent retrograde trafﬁcking of presynaptic
components [35].
The synaptic vesicle cycle is coordinated with a phosphoinositide
cycle that regulates several lipid-protein interactions at the presynaptic
terminal. The initial stage for this process is the phosphorylation of PIto
PI-4 phosphate mediated by PI-4 kinases, which in synaptic vesicles is
mediated by PI4KIIα [36]. Interestingly, the predicted Cdk5 sensitive
site (Ser51) is located adjacent to the di-leucine motif (56ERQPLL61)
that allows PI4KIIα association with the adapter protein (AP)-3, a
sorting receptor that might be relevant to the PI4KIIα targeting of
synaptic vesicles [37].
2.6. Proteins involved in dendritic spine remodeling
In addition to its role at the presynaptic terminal, Cdk5 also phos-
phorylates key substrates at the post-synaptic compartment (Fig. 4).
Our analysis suggests new targets that could contribute to the known
activities of Cdk5 in the formation and remodeling of dendritic
spines, such as TANC proteins and paralemmin-1 (Fig. 4). We identi-
ﬁed putative phosphorylation sites in both TANC1 (Ser445) and
TANC2 (Ser1480). TANCs are adapter proteins which can bind
PSD-95 (Dlg), and that have been proposed to present redundant
roles in the maturation of dendritic spines [38]. Likewise, we also
identiﬁed a putative phosphorylation site in paralemmin-1 (Palm)
(Ser116), a lipid-anchored phosphoprotein located at the cytoplas-
mic face of membranes which plays an essential role in ﬁlopodia for-
mation and dendritic spine maturation [39].
2.7. Proteins involved axon development
Several lines of evidence show that Cdk5 is involved in axon
development. Amongst the many proteins regulating this process are
CTP:phosphocholine cytidylyltransferases (CTTs), key regulatory
enzymes for phosphatidylcholine (PC) synthesis. The CTT-B (Pcyt1b)
isoform is particularly enriched in brain, where it appears to be respon-
sible for PC synthesis in the distal segment of axons [40]. Accordingly,
CTT-B is essential for axonal growth and branching [41]. CTT-B has
been shown to be a substrate for Cdk5 phosphorylation both in vivo
and in vitro [41]. Nevertheless the exact phosphorylation site has not
been previously reported. Here we identify a putative phosphorylation
site located at Ser323, at the C-terminal region. The phosphorylation of
this domain has been shown to regulate the association of CTTswith the
membrane compartment [42].
The Krüppel type Zinc Finger transcription factor B-cell lymphome
(Bcl)-11a/COUP-TP interacting protein (CTIP)-1 is another putative
target of Cdk5, which has been shown to participate in the regulation
of neuronal morphology. Although the molecular mechanism remains
to be clariﬁed, Bcl11a negatively regulates axonal growth and branching
through transcriptional regulation of the microtubule-associated
Fig. 4. Known and new putative Cdk5 substrates in the synapses. The contextual information, such as physical interaction, and colocalization or coexpression between kinases
and substrates, is essential for the reliability of signal transduction. Interestingly, several of the proteins predicted as putative substrates of Cdk5 in this study interact physically
or functionally at synapses with various known substrates of this kinase. CASK, calcium/calmodulin-dependent serine protein kinase; CASKIN, CASK-interacting protein; F-actin,
ﬁlamentous actin; MAST, microtubule-associated serine-threonine kinase; mGluR, metabotropic glutamate receptor; Munc18, mammalian Unc-18 homolog; NMDAR, N-methyl-
D-aspartate receptor; nNOS, neuronal nitric oxide synthase; PI4KIIα, phosphatidylinositol 4-kinase type IIα; PIPKIγ, phosphatidylinositol 4 phosphate 5-kinase type Iγ; PSD-95,
postsynaptic density protein 95; TANC, Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein; P/Q-VGCC, P/Q-voltage-gated calcium channel.
226 D.A. Bórquez et al. / Genomics 101 (2013) 221–228protein (MAP)-1B and the netrin-1 receptor Deleted in Colorectal
Carcinoma (DCC) [43]. Interestingly, the predicted phosphorylation
site (Ser332) in CTIP-1 is contained at a SIRT1 binding interface (resi-
dues 194-378). SIRT1 is a histone deacetylase shown to be essential
for Bcl11a-mediated transcriptional repression [44].3. Conclusions
We report a novel strategy for proteome-wide identiﬁcation of
previously unreported Cdk5 substrates. Through the comprehensive
analysis of the available published data on Cdk5 substrates and their
phosphorylation sites, we developed a computational approach that
uses a PSSM based searchwhichwas complementedwith the biological
information available from multiple studies identifying phosphoryla-
tion sites by mass spectrometry. This allowed us to generate a ranked
list of highly likely potential substrates of Cdk5 which can now be
subjected to further experimental veriﬁcation. The highly stringent
ﬁltering criteria used results in a high number of false negatives, but
permitted the speciﬁcity to be maximized. Our strategy presented
here may be adapted to identify substrates for other kinases, consider-
ing that the only constraint is the availability of enough information
(known phosphorylation sites) in order to generate a reliable PSSM.4. Methods
4.1. Dataset
A comprehensive search was performed of the PubMed database
using the keywords “Cdk5” and “Cyclin-dependent kinase 5”. The
search yielded 166 experimentally characterized phosphorylation
sites in 99 different proteins from 1212 research articles published
online before Sept. 30, 2011. The primary sequences for each protein
were extracted from the Swiss-Prot database. The dataset was divided
into three subgroups according to the experimental determination of
the phosphorylation site, accordingly “in vivo”, “in vitro” and “in vivo
and in vitro”. Although the entire dataset was used to performance
tests (ROC curve, Retrieve percentage), a subset of only 96 sites was
used for the construction of the PSSM. This corresponds to the dataset
named “in vivo and in vitro”with the exception of cellular tumor antigen
p53 (Ser15), which does not correspond to a minimum consensus
sequence of Cdk5.
4.2. Construction of a scansite-suitable PSSM and proteome search
96 phosphorylation sites which are physiologically and unambig-
uously phosphorylated by Cdk5 (in vivo and in vitro dataset) were
227D.A. Bórquez et al. / Genomics 101 (2013) 221–228aligned and the apparition frequency (%) of each of 20 amino acids
was determined within a ﬁfteen-residue window (eight residues
upstream and six residues downstream of the phosphorylation site,
Pro). The frequencywas normalized to themean background frequency
for each amino-acid in the Swiss-Prot databases ofMusmusculus, Homo
sapiens and Rattus norvegicus. Thus, the value “1” indicates that an
amino acid appearing in a position does so in the same percentage as
this amino acid is represented in the proteome. Values lower than 1
indicate that this amino acid is less represented at this position than
whatwould be expected and values above 1 indicate a higher frequency
than expected of the amino acid in this position. Values were incorpo-
rated into a matrix of 15 rows (positions, with the amino acid Pro
ﬁxed in the central position) and 20 columns (amino acids). The devel-
oped matrix was incorporated in the option “Database Search>Search
using an input motif” of Scansite (scansite.mit.edu) [45]. The search
was performed with high-stringency on the Swiss-prot database of
Mus musculus.
4.3. Prediction of protein disorder
The open access server PrDOS (http://prdos.hgc.jp) [46] was used
to predict disordered regions in known substrates of Cdk5 from their
amino acid sequence. The analysis considered the template-based
prediction option and a false positive rate of 5% which equates to a
true positive rate of 65%, according to the ROC curve for the predictor.
The server returns a score between 0.5 and 1 if the amino acid is
found to be in disordered regions.
4.4. Additional tools
The Pfam database (pfam.sanger.ac.uk) [47] was consulted in
order to deﬁne the domain architecture of different proteins. Clustal
Omega [48] was used to perform multiple alignments and determine
residue homology between proteins of different species. PhosphositePlus
(www.phosphosite.org) [49],which collectsmost of the phosphorylation
sites identiﬁed by mass spectrometry studies, was used to determine
whether a site is known to be phosphorylated in vivo or not. Only studies
using mouse cells or tissues were considered. Additional prediction on
Cdk5 substrates was performed using NetPhosK (http://www.cbs.dtu.
dk/services/NetPhosK/) [24] and GPS (http://gps.biocuckoo.org/) [25].
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2013.01.003.
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